The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The world biological drugs market is predicted to gain momentum with rising prevalence of chronic diseases such as cancer and diabetes across the globe. Demand for biological drugs could swell with the expansion of geriatric population at the global level. Currently growing inclination toward adoption of personalized medicines and strong research and development efforts taken to introduce new and powerful biological drugs are foretold to set the tone for a significant rise in demand.
The global Biological Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Biological Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biological Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Biological Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Biological Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bristol-Myers Squibb
Eli Lilly
Shire
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Therapeutic Protein
Monoclonal Antibody
Vaccine
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Table of Contents
Report Introduction
1 Industry Overview of Biological Drugs
1.1 Definition of Biological Drugs
1.2 Biological Drugs Segment by Type
1.2.1 Global Biological Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.3 Biological Drugs Segment by Applications
1.3.1 Global Biological Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Biological Drugs Overall Market
1.4.1 Global Biological Drugs Revenue (2014-2025)
1.4.2 Global Biological Drugs Production (2014-2025)
1.4.3 North America Biological Drugs Status and Prospect (2014-2025)
1.4.4 Europe Biological Drugs Status and Prospect (2014-2025)
1.4.5 China Biological Drugs Status and Prospect (2014-2025)
1.4.6 Japan Biological Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Biological Drugs Status and Prospect (2014-2025)
1.4.8 India Biological Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biological Drugs
2.3 Manufacturing Process Analysis of Biological Drugs
2.4 Industry Chain Structure of Biological Drugs
3 Development and Manufacturing Plants Analysis of Biological Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Biological Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Biological Drugs
3.4 Recent Company Developments and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Biological Drugs Production and Capacity Analysis
4.2 Biological Drugs Revenue Analysis
4.3 Biological Drugs Price Analysis
4.4 Market Concentration Degree
5 Biological Drugs Regional Market Analysis
5.1 Biological Drugs Production by Regions
5.1.1 Global Biological Drugs Production by Regions
5.1.2 Global Biological Drugs Revenue by Regions
5.2 Biological Drugs Consumption by Regions
5.3 North America Biological Drugs Market Analysis
5.3.1 North America Biological Drugs Production
5.3.2 North America Biological Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Biological Drugs Import and Export
5.4 Europe Biological Drugs Market Analysis
5.4.1 Europe Biological Drugs Production
5.4.2 Europe Biological Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Biological Drugs Import and Export
5.5 China Biological Drugs Market Analysis
5.5.1 China Biological Drugs Production
5.5.2 China Biological Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Biological Drugs Import and Export
5.6 Japan Biological Drugs Market Analysis
5.6.1 Japan Biological Drugs Production
5.6.2 Japan Biological Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Biological Drugs Import and Export
5.7 Southeast Asia Biological Drugs Market Analysis
5.7.1 Southeast Asia Biological Drugs Production
5.7.2 Southeast Asia Biological Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Biological Drugs Import and Export
5.8 India Biological Drugs Market Analysis
5.8.1 India Biological Drugs Production
5.8.2 India Biological Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Biological Drugs Import and Export
6 Biological Drugs Segment Market Analysis (by Type)
6.1 Global Biological Drugs Production by Type
6.2 Global Biological Drugs Revenue by Type
6.3 Biological Drugs Price by Type
7 Biological Drugs Segment Market Analysis (by Application)
7.1 Global Biological Drugs Consumption by Application
7.2 Global Biological Drugs Consumption Market Share by Application (2014-2019)
8 Biological Drugs Major Manufacturers Analysis
8.1 Bristol-Myers Squibb
8.1.1 Bristol-Myers Squibb Biological Drugs Production Sites and Area Served
8.1.2 Bristol-Myers Squibb Report Overview, Application and Specification
8.1.3 Bristol-Myers Squibb Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly
8.2.1 Eli Lilly Biological Drugs Production Sites and Area Served
8.2.2 Eli Lilly Report Overview, Application and Specification
8.2.3 Eli Lilly Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Shire
8.3.1 Shire Biological Drugs Production Sites and Area Served
8.3.2 Shire Report Overview, Application and Specification
8.3.3 Shire Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer Biological Drugs Production Sites and Area Served
8.4.2 Pfizer Report Overview, Application and Specification
8.4.3 Pfizer Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Amgen
8.5.1 Amgen Biological Drugs Production Sites and Area Served
8.5.2 Amgen Report Overview, Application and Specification
8.5.3 Amgen Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 F. Hoffmann-La Roche
8.6.1 F. Hoffmann-La Roche Biological Drugs Production Sites and Area Served
8.6.2 F. Hoffmann-La Roche Report Overview, Application and Specification
8.6.3 F. Hoffmann-La Roche Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Johnson & Johnson
8.7.1 Johnson & Johnson Biological Drugs Production Sites and Area Served
8.7.2 Johnson & Johnson Report Overview, Application and Specification
8.7.3 Johnson & Johnson Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Merck
8.8.1 Merck Biological Drugs Production Sites and Area Served
8.8.2 Merck Report Overview, Application and Specification
8.8.3 Merck Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Abbott Laboratories
8.9.1 Abbott Laboratories Biological Drugs Production Sites and Area Served
8.9.2 Abbott Laboratories Report Overview, Application and Specification
8.9.3 Abbott Laboratories Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Baxter
8.10.1 Baxter Biological Drugs Production Sites and Area Served
8.10.2 Baxter Report Overview, Application and Specification
8.10.3 Baxter Biological Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Novartis
8.12 Biogen
8.13 GlaxoSmithKline
9 Development Trend of Analysis of Biological Drugs Market
9.1 Global Biological Drugs Market Trend Analysis
9.1.1 Global Biological Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Biological Drugs Regional Market Trend
9.2.1 North America Biological Drugs Forecast 2019-2025
9.2.2 Europe Biological Drugs Forecast 2019-2025
9.2.3 China Biological Drugs Forecast 2019-2025
9.2.4 Japan Biological Drugs Forecast 2019-2025
9.2.5 Southeast Asia Biological Drugs Forecast 2019-2025
9.2.6 India Biological Drugs Forecast 2019-2025
9.3 Biological Drugs Market Trend (Product Type)
9.4 Biological Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Biological Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
We employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach
Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.
Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity
Pricing Scenario
Cost Margin Analysis
Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price
Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. Insert Image